Our lentiviral vector platform LentiForge enables efficient, stable, and precise gene delivery to both dividing and non-dividing cells, ensuring long-term therapeutic expression. Designed with enhanced safety and payload flexibility, it serves as a robust backbone for next-generation cell and gene therapy development.
Our INViMAC (In-Vivo CAR-Macrophage Engineering) platform enables precise genetic reprogramming of macrophages within the body to target and remodel the tumor microenvironment. By harnessing innate immune mechanisms, INViMAC offers a powerful, non-invasive approach for durable and targeted immunotherapy against solid tumors.
Our INViT (In-Vivo CAR-T) platform revolutionizes cell therapy by enabling direct generation of CAR-T cells inside the patient’s body, eliminating the need for ex-vivo manipulation. This breakthrough approach ensures faster, scalable, and patient-friendly immunotherapy with enhanced precision and accessibility.
Our XpressForge platform delivers high-yield, precision-controlled custom peptide and protein expression for research and therapeutic applications. Designed for speed, scalability, and purity, it accelerates the development of next-generation biotherapeutics and diagnostic tools.
Our MCloneForge platform enables rapid and reliable generation of stable monoclonal cell lines for biotherapeutic production and functional studies. Through advanced screening and gene integration technologies, it ensures high expression stability, consistency, and scalability from discovery to manufacturing.
Our ForgeClassics portfolio offers a curated range of classical proteins and antibodies essential for research, diagnostics, and therapeutic development. Each product is crafted with high purity, reproducibility, and performance consistency to support cutting-edge scientific innovation.
Copyright © 2025 Cytoforge Therapeutics Private Limited - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.